James Young

James W. Young, PhD joined 5AM Ventures in 2006 as a Venture Partner. James Young has been involved with Sunesis since 2000, as Chief Executive Officer, Executive Chairman and currently as Chairman. Prior to Sunesis, James Young was Senior Vice President, Research and Development and Group Vice President at ALZA Corporation. Before joining ALZA, James Young was President of the Pharmaceuticals Division of Affymax, N.V., and Senior Vice President and General Manager of the Pharmaceuticals Division at Sepracor. Previously, James Young was Vice President of Research at Zoecon/Sandoz Crop Protection Corporation. James Young served as Executive Chairman and then as a Director of Pearl until its acquisition by AstraZeneca.